Blood Products Advisory Committee

Topic: Reclassification of Human Immunodeficiency Virus (HIV) drug sensitivity assays.
Date: 09/17/1999

Committee: Blood Products Advisory Committee

The agency described the general classification of biological products, and asked the committee for a recommendation for classification of viral resistance assays. The classification assignment determines how these assays are regulated by the agency.

• Notice of Meeting (PDF - 20 KB)
• Briefing Information
• Background Information (PDF - 225 KB)
• Transcript (rich text format)
• Transcript PDF, pages 1 - 100) (4 MB)
• Transcript (PDF, pages 101 - 195) (3.8 MB)